Critical Outcome Technologies Inc. Share Price Toronto S.E.
Equities
COT
CA22675B1031
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- CAD | - |
|
Sales 2018 | - | Sales 2019 | - | Capitalization | 16.12L 22.03L 13Cr |
---|---|---|---|---|---|
Net income 2018 | -40L -54.68L -33Cr | Net income 2019 | -20L -27.34L -17Cr | EV / Sales 2018 | - |
Net cash position 2018 | 40.73T 55.68T 34.03L | Net cash position 2019 | 24.64T 33.69T 20.59L | EV / Sales 2019 | - |
P/E ratio 2018 |
-1.11
x | P/E ratio 2019 |
-0.6
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 69.18% |
Managers | Title | Age | Since |
---|---|---|---|
Alison D. Silva
PSD | President | 46 | 01/15/01 |
Debi Sanderson
COO | Chief Operating Officer | - | - |
Chief Tech/Sci/R&D Officer | 61 | 12/17/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 01/18/01 | |
John C. Drake
CHM | Chairman | - | 20/07/20 |
Alison D. Silva
PSD | President | 46 | 01/15/01 |
1st Jan change | Capi. | |
---|---|---|
+20.63% | 13TCr | |
+23.21% | 12TCr | |
+25.36% | 2.77TCr | |
-20.17% | 2.03TCr | |
-17.08% | 1.68TCr | |
-18.07% | 1.56TCr | |
+11.92% | 1.48TCr | |
-47.70% | 1.46TCr | |
+58.32% | 1.44TCr |
- Stock Market
- Equities
- COTQF Stock
- COT Stock